Near-infrared spectroscopy device selection affects intervention management for cerebral desaturation during cardiopulmonary bypass surgery
Objective Currently, several near-infrared spectroscopy oximetry devices are used for detecting cerebral ischemia during cardiopulmonary bypass (CPB) surgery. We investigated whether two different models of near-infrared spectroscopy oximetry devices affect the assessment of cerebral ischemia and it...
Saved in:
| Published in | General thoracic and cardiovascular surgery Vol. 70; no. 1; pp. 11 - 15 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
Springer Singapore
01.01.2022
Springer Nature B.V |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1863-6705 1863-6713 1863-6713 |
| DOI | 10.1007/s11748-021-01659-5 |
Cover
| Summary: | Objective
Currently, several near-infrared spectroscopy oximetry devices are used for detecting cerebral ischemia during cardiopulmonary bypass (CPB) surgery. We investigated whether two different models of near-infrared spectroscopy oximetry devices affect the assessment of cerebral ischemia and its management during CPB.
Methods
From January 2017 to August 2017, 70 adult cardiovascular surgery cases were randomly assigned to 1 of 2 different near-infrared spectroscopy oximetry devices. The devices were INVOS 5100C (Medtronic, Minneapolis, MN, USA) (group I;
n
= 35) and FORE-SIGHT ELITE (CAS Medical Systems, Branford, CT, USA) (group F;
n
= 35).
Results
There were no significant differences in patient characteristics. The rSO
2
values were significantly higher for patients in group F than for patients in group I. Scalp–Cortex distance showed negative correlations with the mean rSO
2
values in group I (
P
= 0.01). Interventions for low rSO
2
during CPB for groups I and F were increase perfusion flow (13:5;
P
= 0.03), blood transfusion (7:1;
P
= 0.02), and both (6:1;
P
= 0.04), respectively. The Scalp–Cortex distance in group I was significantly longer in patients who required intervention than in patients who did not (17.1 ± 2.5 vs 15.1 ± 1.6 mm;
P
= 0.007).
Conclusions
It is inappropriate to use the same intervention criteria for different near-infrared spectroscopy oximetry devices. Moreover, brain atrophy influence rSO
2
values depending on device selection. It is important to note that inappropriate device selection may misguide perfusionists into performing unnecessary or excessive intervention during CPB. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| ISSN: | 1863-6705 1863-6713 1863-6713 |
| DOI: | 10.1007/s11748-021-01659-5 |